Impaired immune reconstitution post sequential high-dose chemotherapy and peripheral blood progenitor cell (PBPC) infusion.

被引：0
|
作者：
Stein, DT
Mackall, CL
Bare, CV
Brown, MR
Carter, CS
Casey, N
Yu, MY
Fleisher, TA
Leitman, SF
Shearer, GM
Wexler, L
Gress, RE
机构：
[1] NCI,DEPT TRANSFUS MED,BETHESDA,MD 20892
[2] NIH,DEPT CLIN PATHOL,BETHESDA,MD 20892
来源：
PEDIATRIC RESEARCH | 1996年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：962 / 962
页数：1
相关论文
共 50 条
  • [21] High-dose chemotherapy with subsequent support therapy listing peripheral blood progenitor cells (PBPC) in patients with germ testicular cancer
    Naponucká, J
    Boublíková, L
    Charvát, J
    Kalanin, J
    Greplová, M
    Lukásova, M
    Abrahámova, J
    BONE MARROW TRANSPLANTATION, 1998, 21 : S231 - S231
  • [22] High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancer
    Rodenhuis, S
    Huitema, ADR
    van Dam, FSAM
    de Vries, EGE
    Beijnen, JH
    CANCER JOURNAL, 2000, 6 : S125 - S130
  • [23] Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma
    Hequet, O
    Dumontet, C
    El Jaafari-Corbin, A
    Salles, G
    Espinouse, D
    Arnaud, P
    Thieblemont, C
    Bouafia, F
    Coiffier, B
    BONE MARROW TRANSPLANTATION, 2002, 29 (06) : 544 - 544
  • [24] Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma
    O Hequet
    C Dumontet
    A El Jaafari-Corbin
    G Salles
    D Espinouse
    P Arnaud
    C Thieblemont
    F Bouafia
    B Coiffier
    Bone Marrow Transplantation, 2002, 29 : 544 - 544
  • [25] CD34 CONTENT OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IS THE SINGLE MOST POWERFUL PREDICTOR OF RECOVERY KINETICS IN PATIENTS RECEIVING MYELOABLATIVE HIGH-DOSE CHEMOTHERAPY (HDC) AND PBPC INFUSION
    WEAVER, CH
    BIRCH, R
    SCHWARTZBERG, L
    PALMER, P
    WEST, W
    HAZELTON, B
    BLOOD, 1994, 84 (10) : A351 - A351
  • [26] Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients
    Zambelli, A
    Montagna, D
    Da Prada, GA
    Maccario, R
    Zibera, C
    Moretta, A
    Ponchio, L
    Lozza, L
    Baiardi, P
    Maserati, R
    Marone, P
    Della Cuna, GR
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3701 - 3708
  • [27] High-dose chemotherapy and peripheral blood progenitor cells with respect to solid tumors
    Rosti, G
    Ferrante, P
    Tienghi, A
    Turci, D
    Dazzi, C
    Leoni, M
    Fiorentini, G
    Ferrari, E
    Zornetta, L
    Marangolo, M
    TUMORI, 1996, 82 (02) : S19 - S22
  • [28] TANDEM CYCLES OF HIGH-DOSE CHEMOTHERAPY (HDC) SUPPORTED WITH G-CSF PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)
    MEISENBERG, B
    MILLER, W
    MCMILLAN, R
    BLOOD, 1994, 84 (10) : A715 - A715
  • [29] Repetitive high-dose therapy with peripheral blood progenitor cell (PBPC) support for metastatic (MBC) and locally advanced breast cancer
    不详
    Bone Marrow Transplantation, 2000, 26 (Suppl 1) : S7 - S8
  • [30] Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution
    Sauer, Sandra
    Pavel, Petra
    Schmitt, Anita
    Cremer, Martin
    Kriegsmann, Mark
    Bruckner, Thomas
    Jordan, Karin
    Wuchter, Patrick
    Mueller-Tidow, Carsten
    Kriegsmann, Katharina
    BMC CANCER, 2020, 20 (01)
12345